FOUNDERS FINANCIAL SECURITIES LLC

Broker-Dealer

Position in GILD — Gilead Sciences, Inc.

CIK 1342396 TOWSON, MD

Position in GILD

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,051,275

-$101,314 QoQ

Shares Held

8,321

+0.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#1,047

of 2,266 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 3% None 97%

Healthcare · as of Jun 30, 2026

FOUNDERS FINANCIAL SECURITIES LLC holds $21,446,689 across 11 Drug Manufacturers - General names. GILD ranks #8 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	23,408	$5,944,929
2	AMGN	Amgen Inc	8,037	$2,910,358
3	MRK	Merck & Co., Inc.	19,290	$2,478,765
4	ABBV	AbbVie Inc.	9,802	$2,466,575
5	AZN	Astrazeneca PLC	12,714	$2,410,828
6	LLY	ELI LILLY & Co	1,169	$1,402,133
7	GSK	GSK plc	21,673	$1,136,098
8	GILD	Gilead Sciences, Inc. This page	8,321	$1,051,275

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,051,275	8,321	+0.6%	Shares	Defined	2026-07-31
2026-03-31	$1,152,589	8,270	-0.4%	Shares	Defined	2026-04-17
2025-12-31	$1,019,232	8,304	+4.1%	Shares	Sole	2026-02-10
2025-09-30	$885,669	7,979	+67.9%	Shares	Sole	2025-10-15
2025-06-30	$526,854	4,752	+63.6%	Shares	Sole	2025-08-06
2025-03-31	$325,393	2,904	-71.0%	Shares	Sole	2025-05-12
2024-12-31	$924,161	10,005	-18.6%	Shares	Sole	2025-02-10
2024-09-30	$1,029,890	12,284	+0.3%	Shares	Sole	2024-11-12
2024-06-30	$840,129	12,245	+3.5%	Shares	Sole	2024-08-02
2024-03-31	$866,694	11,832	+7.6%	Shares	Sole	2024-04-17
2023-12-31	$891,028	10,999	+17.9%	Shares	Sole	2024-02-06
2023-09-30	$699,265	9,331	+260.5%	Shares	Sole	2023-10-17
2023-03-31	$214,726	2,588	+3.4%	Shares	Sole	2023-05-04
2022-12-31	$214,968	2,504	—	Shares	Sole	2023-02-08
No filing history on record for this holder in this stock.